PC-SPES down-regulates COX-2 via inhibition of NF-κB and C/EBPβ in non-small cell lung cancer cells

International Journal of Oncology

Volumn 29, Issue 2, 2006, Pages 453-461

  Ikezoe, Takayuki ^a,c   Yang, Yang ^c   Saitoh, Takayuki ^a   Heber, David ^b   McKenna, Robert ^a   Taguchi, Hirokuni ^c   Koeffler, H Phillip ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KOCHI UNIVERSITY   (Japan)

Author keywords

C EBPs; COX 2; Nf B; PC SPES

Indexed keywords

ANTINEOPLASTIC AGENT; CCAAT ENHANCER BINDING PROTEIN BETA; HERBACEOUS AGENT; HERBAL PREPARATION PC SPES; HERBAL PREPARATION PC-SPES; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; DOWN-REGULATION; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; NF-KAPPA B;

EID: 34548550780     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.2.453     Document Type: Article

References (31)

1. Smith WL and Marnett LJ: Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1083: 1-17, 1991.
2. De Witt DL: Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1083: 121-134, 1991.
3. Suh N, Honda T, Finlay HJ, et al: Novel terpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res 58: 717-723, 1998. (Pubitemid 28099483)
4. Rao CV, Indranie C, Simi B, Manning PT, Connor JR and Reddy BS: Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62: 165-170, 2002. (Pubitemid 34074001)
5. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and Dubois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994. (Pubitemid 24294584)
6. Gupta RA and Dubois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1: 11-21, 2001. (Pubitemid 33741877)
7. Di Paola RS, Zhang H, Lambert GH, et al: Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 339: 785-791, 1998. (Pubitemid 28447451)
8. Small EJ, Frohlich MW, Bok R, et al: Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 18: 3595-3603, 2000.
9. Kubota T, Hisatake J, Hisatake Y, et al: PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo. Prostate 42: 163-171, 2000. (Pubitemid 30080414)
10. Huerta S, Arteaga JR, Irwin RW, Ikezoe T, Heber D and Koeffler HP: PC-SPES inhibits colon cancer growth in vitro and in vivo. Cancer Res 62: 5204-5209, 2002. (Pubitemid 35024591)
11. Δ716 knockout mice by inhibition of cyclooxygenase 2. Cell 87: 803-809, 1996.
12. Δ716 mouse by refecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61: 1733-1740, 2001.
13. Ikezoe T, Chen S, Xian-Jun T, Heber D, Taguchi H and Koeffler HP: Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol 23: 1187-1193, 2003.
14. Wardlaw SA, Zhang N and Belinsky SA: Transcriptional regulation of basal cyclooxygenase-2 expression in murine lung tumor-derived cell lines by CCAAT/enhancer-binding protein and activating transcription factor/cAMP response element-binding protein. Mol Pharmacol 62: 326-333, 2002. (Pubitemid 34804113)
15. Wadleigh DJ, Reddy ST, Kopp E, Ghosh S and Herschman HR: Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 275: 6259-6266, 2000. (Pubitemid 30129916)
16. Sovak M, Seligson AL, Konas M, Hajduch M, Dolezal M, Machala M and Nagourney R: Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst 94: 1275-1281, 2002.
17. Ikezoe T, Chen S, Yang Y, Heber D, Taguchi H and Koeffler HP: PC-SPES: Molecular mechanism to induce apoptosis and downregulate expression of PSA in LNCaP human prostate cancer cells. Int J Oncol 23: 1461-1470, 2003.
18. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD and Tenen DG: Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 62: 528-534, 2002. (Pubitemid 34106427)
19. Cieslik K, Zhu Y and Wu KK: Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer- binding protein-beta binding via a common signaling pathway. J Biol Chem 277: 49304-49310, 2002. (Pubitemid 36014360)
20. Bundy LM and Sealy L: CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 13: 869-883, 2003.
21. Oya M, Horiguchi A, Mizuno R, Marumo K and Murai M: Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma. Clin Cancer Res 9: 1021-1027, 2003. (Pubitemid 36323706)
22. Zhu S, Yoon K, Sterneck E, Johnson PF and Smart RC: CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci USA 99: 207-212, 2002. (Pubitemid 34060342)
23. Shao J, Sheng H, Inoue H, Morrow JD and Dubois RN: Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol Chem 275: 33951-33956, 2000.
24. Bonham M, Arnold H, Montgomery B and Nelson PS: Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. Cancer Res 62: 3920-3924, 2002. (Pubitemid 34791052)
25. Bigler D, Gulding KM, Dann R, Sheabar FZ, Conaway MR and Theodorescu D: Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action. Oncogene 22: 1261-1272, 2003. (Pubitemid 36363391)
26. Bonham MJ, Galkin A, Montgomery B, Stahl WL, Agus D and Nelson PS: Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition. J Natl Cancer Inst 94: 1641-1647, 2002. (Pubitemid 35378730)
27. Lekstrom-Himes J and Xanthopoulos KG: Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273: 28545-28548, 1998. (Pubitemid 28507532)
28. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L and Xanthopoulos KG: Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha. J Biol Chem 271: 24753-24760, 1996. (Pubitemid 26333221)
29. Pabst T, Mueller BU, Zhang P, et al: Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27: 263-270, 2001. (Pubitemid 32201846)
30. Gombart AF, Hofmann WK, Kawano S, et al: Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 99: 1332-1240, 2002. (Pubitemid 34547089)
31. Ikezoe T, Chen SS, Heber D, Taguchi H and Koeffler HP: Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest. Prostate 49: 285-292, 2001. (Pubitemid 33117004)